Home Healthcare IT Global Shingles Vaccine Market Size, Top Share, Report to 2032

Shingles Vaccine Market Size, Share & Trends Analysis Report By Product (Shingrix, Zostavax, SKYZoster), By Vaccine Type (Recombinant Vaccine, Live Attenuated Vaccine) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRHI55647DR
Last Updated : 24,Jul 2024
Author : Straits Research
Starting From
USD 995
Buy Now
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Shingles Vaccine Market, By Product (2020-2032)
    1. Shingrix
    2. Zostavax
    3. SKYZoster
  2. Shingles Vaccine Market, By Vaccine Type (2020-2032)
    1. Recombinant Vaccine
    2. Live Attenuated Vaccine
    1. North America
      1. North America Shingles Vaccine Market, By Product
        1. Shingrix
          1. Zostavax
            1. SKYZoster
            2. North America Shingles Vaccine Market, By Vaccine Type
              1. Recombinant Vaccine
                1. Live Attenuated Vaccine
                2. U.S.
                  1. U.S. Shingles Vaccine Market, By Product
                    1. Shingrix
                      1. Zostavax
                        1. SKYZoster
                        2. U.S. Shingles Vaccine Market, By Vaccine Type
                          1. Recombinant Vaccine
                            1. Live Attenuated Vaccine
                          2. Canada
                        3. Europe
                          1. Europe Shingles Vaccine Market, By Product
                            1. Shingrix
                              1. Zostavax
                                1. SKYZoster
                                2. Europe Shingles Vaccine Market, By Vaccine Type
                                  1. Recombinant Vaccine
                                    1. Live Attenuated Vaccine
                                    2. U.K.
                                      1. U.K. Shingles Vaccine Market, By Product
                                        1. Shingrix
                                          1. Zostavax
                                            1. SKYZoster
                                            2. U.K. Shingles Vaccine Market, By Vaccine Type
                                              1. Recombinant Vaccine
                                                1. Live Attenuated Vaccine
                                              2. Germany
                                              3. France
                                              4. Spain
                                              5. Italy
                                              6. Russia
                                              7. Nordic
                                              8. Benelux
                                              9. Rest of Europe
                                            3. APAC
                                              1. APAC Shingles Vaccine Market, By Product
                                                1. Shingrix
                                                  1. Zostavax
                                                    1. SKYZoster
                                                    2. APAC Shingles Vaccine Market, By Vaccine Type
                                                      1. Recombinant Vaccine
                                                        1. Live Attenuated Vaccine
                                                        2. China
                                                          1. China Shingles Vaccine Market, By Product
                                                            1. Shingrix
                                                              1. Zostavax
                                                                1. SKYZoster
                                                                2. China Shingles Vaccine Market, By Vaccine Type
                                                                  1. Recombinant Vaccine
                                                                    1. Live Attenuated Vaccine
                                                                  2. Korea
                                                                  3. Japan
                                                                  4. India
                                                                  5. Australia
                                                                  6. Singapore
                                                                  7. Taiwan
                                                                  8. South East Asia
                                                                  9. Rest of Asia-Pacific
                                                                3. Middle East and Africa
                                                                  1. Middle East and Africa Shingles Vaccine Market, By Product
                                                                    1. Shingrix
                                                                      1. Zostavax
                                                                        1. SKYZoster
                                                                        2. Middle East and Africa Shingles Vaccine Market, By Vaccine Type
                                                                          1. Recombinant Vaccine
                                                                            1. Live Attenuated Vaccine
                                                                            2. UAE
                                                                              1. UAE Shingles Vaccine Market, By Product
                                                                                1. Shingrix
                                                                                  1. Zostavax
                                                                                    1. SKYZoster
                                                                                    2. UAE Shingles Vaccine Market, By Vaccine Type
                                                                                      1. Recombinant Vaccine
                                                                                        1. Live Attenuated Vaccine
                                                                                      2. Turkey
                                                                                      3. Saudi Arabia
                                                                                      4. South Africa
                                                                                      5. Egypt
                                                                                      6. Nigeria
                                                                                      7. Rest of MEA
                                                                                    3. LATAM
                                                                                      1. LATAM Shingles Vaccine Market, By Product
                                                                                        1. Shingrix
                                                                                          1. Zostavax
                                                                                            1. SKYZoster
                                                                                            2. LATAM Shingles Vaccine Market, By Vaccine Type
                                                                                              1. Recombinant Vaccine
                                                                                                1. Live Attenuated Vaccine
                                                                                                2. Brazil
                                                                                                  1. Brazil Shingles Vaccine Market, By Product
                                                                                                    1. Shingrix
                                                                                                      1. Zostavax
                                                                                                        1. SKYZoster
                                                                                                        2. Brazil Shingles Vaccine Market, By Vaccine Type
                                                                                                          1. Recombinant Vaccine
                                                                                                            1. Live Attenuated Vaccine
                                                                                                          2. Mexico
                                                                                                          3. Argentina
                                                                                                          4. Chile
                                                                                                          5. Colombia
                                                                                                          6. Rest of LATAM

                                                                                                      Related Reports

                                                                                                      Global Report
                                                                                                      The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                      Buy Now

                                                                                                      Purchase Benefits

                                                                                                      • Eligible for a free updated report next year
                                                                                                      • Completely customizable scope
                                                                                                      • 30% discount on your next purchase
                                                                                                      • Dedicated account manager
                                                                                                      • Query resolution within 24 hours
                                                                                                      • Permission to print the report


                                                                                                      We are featured on :